Non-invasive in vivo analysis of early metastatic processes
Non-invasive in vivo analysis of early metastatic processes
批准号:
09470506
负责人:
OKU Naoto
金额:
$7.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For elucidating early phase of tumor metastasis, we developed non-invasive method to determine metastatic tumor cell trafficking by PET. We have already observed the correlation between metastatic potential and metastatic cell accumulation in a target tissues. In the present study, we firstly clarified the involvement of selectins in the early tumor cell trafficking. We also observed sulfatide, a ligand for selectins, suppressed tumor metastasis. Secondly, we investigated the role of integrins in tumor metastatic process by using integrin transfectants. CHO cells were transfected with a chain of integrins, I.e., α2, α3, α4, α6, α9 and av. PET analysis indicated that integrin αvβ1 and α4β1 enhanced tumor cell accumulation in a target tissue. Furthermore, useful evidences were obtained about involvement of integrin avb3 in liver metastasis. Thirdly, we investigated the role of immune surveillance on the suppression of tumor metastasis. If small number of tumor cells were injected in experimental metastatic model, metastasis was not observed due to removal of tumor cells from target by immune defense system. In fact, metastasis was observed in mice which were pretreated for the depletion of macrophages even when small number of tumor cells were injected. And, in this case, removal of tumor cells from target tissues was suppressed by the determination of PET. Therefore, we clearly demonstrated that macrophage play an important role for suppressing metastasis in the early stage of metastatic processes.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tomohiro Asai, et al.: "5'-O-dipalmitoylphosphatidyl 2'-C-Cyano-2'-deoxy-1-β-D-arabiono-pentofuranosyl-cytosine Is Enhanced by Long-circulating Liposomalization"Biol. Pharm. Bull.. 21. 766-771 (1998)
Tomohiro Asai 等人:“5-O-二棕榈酰磷脂酰 2-C-氰基-2-脱氧-1-β-D-阿拉伯-呋喃戊糖基-胞嘧啶通过长循环脂质体化得到增强”Biol Bull。 ..21.766-771 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hironori Kikkawa, Daisei Miyamoto, Hidetoshi Imafuku, Chieko Koike, Yasuno Suzuki, Shoji Okada, Hideo Tsuka, Tatsuro Irimura and Naoto Oku: "Role of Sialylglycoconjugate(s) in the Initial Phase of Metastasis of Liver-metastatic RAW117 Lymphoma Cells."Jpn.
Hironori Kikkawa、Daisei Miyamoto、Hidetoshi Imafuku、Chieko Koike、Yasuno Suzuki、Shoji Okada、Hideo Tsuka、Tatsuro Irimura 和 Naoto Oku:“唾液酸糖复合物在肝转移性 RAW117 淋巴瘤细胞转移初始阶段的作用。”Jpn
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hironori Kikkawa,et al.: "Possible role immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cell"FEBS Lett.. 467. 211-216 (2000)
Hironori Kikkawa 等人:“免疫监视在 B16BL6 黑色素瘤细胞产生的转移初始阶段的可能作用”FEBS Lett.. 467. 211-216 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dail Ishikawa, et al.: "GD1α-Replica peptides Functionally Mimic GD1 α, an Adhesion Molecule of Metastaric Tumor Cells, and Suppress the Tum or Metastasis"FEBS Lett.. 441. 20-24 (1998)
Dail Ishikawa 等人:“GD1α-复制肽功能性地模仿 GD1α(转移性肿瘤细胞的粘附分子)并抑制肿瘤或转移”FEBS Lett.. 441. 20-24 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masako Takikawa, et al.: "Suppression of GD1 α ganglioside-mediated tum or metastasis by liposomalized WHW-peptide"FEBS Lett.. 466. 381-384 (2000)
Masako Takikawa 等:“通过脂质体化 WHW-肽抑制 GD1 α 神经节苷脂介导的肿瘤或转移”FEBS Lett.. 466. 381-384 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 33 条
Development of FA-Snap, a smart DDS drug, for proposing an innovative therapeutic modality of ischemic stroke.
-
批准号:16H05081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2016
-
负责人:OKU Naoto
-
依托单位:
New development of diagnostic and therapeutic modality for ischemia/reperfusion injury by intelligent DDS
-
批准号:23249005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2011
-
负责人:OKU Naoto
-
依托单位:
Development of novel nanoparticles for DDS, and establishment of Therapeutic modality for brain ischemia by use of these nanoparticles.
-
批准号:22659010
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.98万
-
财政年份:2010
-
负责人:OKU Naoto
-
依托单位:
A novel targeting DDS for the treatment of autoimmune diseases and allergy
-
批准号:20390014
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2008
-
负责人:OKU Naoto
-
依托单位:
Development of Radical Treatment Modality for Curing Allergies and Immune Diseases by a Novel Consept, RTDDS
-
批准号:18390052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.0万
-
财政年份:2006
-
负责人:OKU Naoto
-
依托单位:
Establishment of Antineovascular Therapy by use of Structure-recognizing targeting probes
-
批准号:15390050
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2003
-
负责人:OKU Naoto
-
依托单位:
Angiogenesis Suppression and Cancer Treatment by Use of Neovascular Targeted Probe
-
批准号:12470507
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2000
-
负责人:OKU Naoto
-
依托单位:
Cancer Photodynamic Therapy by use of RES-avoiding Liposomes
-
批准号:07672424
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:OKU Naoto
-
依托单位:
DEVELOPMENT OF FUNCTIONAL RES-AVOIDING LIPOSOMES AND THEIR USE IN CANCER THERAPY
-
批准号:05671874
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:OKU Naoto
-
依托单位:
Study of the Signal Transduction of and Cellular Response (Growth Stimulation and Cytotoxicity) to Tumor Necrosis Factor
-
批准号:02671023
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1990
-
负责人:OKU Naoto
-
依托单位:
海外基金